Antiviral use in healthcare workers-A systematic review

Fazia Tadount; Zineb Laghdir; Caroline Quach

doi:10.1017/ice.2021.79

Antiviral use in healthcare workers-A systematic review

Infect Control Hosp Epidemiol. 2022 Apr;43(4):518-523. doi: 10.1017/ice.2021.79. Epub 2021 Mar 15.

Authors

Fazia Tadount^{1

2}, Zineb Laghdir^{1

2}, Caroline Quach^{1

2

3

4}

Affiliations

¹ Research Institute, CHU Sainte-Justine, Montreal, Québec, Canada.
² Infection Prevention & Control, CHU Sainte-Justine, Montreal, Québec, Canada.
³ Department of Pediatric Laboratory Medicine, CHU Sainte-Justine, Montreal, Québec, Canada.
⁴ Department of Microbiology, Infectious Diseases, and Immunology, Faculty of Medicine, University of Montreal, Montreal, Québec, Canada.

PMID: 33715650
DOI: 10.1017/ice.2021.79

Abstract

Neuraminidase inhibitors (NAIs) are likely part of the rapid response and control in influenza pandemics and institutional outbreaks. We conducted a systematic review to appraise the current evidence on the use of NAIs among healthcare workers in the context of an influenza pandemic.

Publication types

Systematic Review
Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents* / therapeutic use
Enzyme Inhibitors / therapeutic use
Health Personnel
Humans
Influenza, Human* / drug therapy
Influenza, Human* / epidemiology
Influenza, Human* / prevention & control
Neuraminidase / therapeutic use
Oseltamivir / therapeutic use
Zanamivir / therapeutic use

Substances

Antiviral Agents
Enzyme Inhibitors
Oseltamivir
Neuraminidase
Zanamivir